ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 IN HOSPITAL
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has spread rapidly across the globe and had infected over 25 million people and caused over 1 million deaths.
The transmission of respiratory viruses can occur through inhalation of respiratory droplets (particles >5 mm in diameter) and infectious aerosols.
Environmental sampling can provide important information about the spread of healthcare-associated infections.
Virus sampling frequency was until now generally low, meaning that results often represented a snapshot in time and place.
In a rapidly evolving outbreak, there is a need to gain rapid understanding of certain trends, and whilst snapshot samples by themselves cannot be considered representative, they can, when taken together, provide useful data relating to type, level and location of environmental contamination.
The goal to obtain a representative number of samples is reached with the new air sampler AIRBIO.ONE RAPID VIRUS to be used in combination with the rapid PCR test.
It is a portable, compact instrument to be used in hospital premises.
The new “AIRBIO.ONE RAPID VIRUS” air sampler produced by ORUM INTERNATIONAL (Milan, Italy) in combination with the rapid PCR tests is a portable compact instrument, and it is the answer to this request.